» Articles » PMID: 7423203

Antibody Targeting of Liposomes: Cell Specificity Obtained by Conjugation of F(ab')2 to Vesicle Surface

Overview
Journal Science
Specialty Science
Date 1980 Oct 31
PMID 7423203
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

A method devised for conjugating liposomes with protein resulted in the binding of up to 200 micrograms of immunoglobulin G per micromole of lipid. The coupling of antibody to human erythrocyte F(ab')2 in vesicles (140 molecules per vesicle) by this method caused a 200-fold increase in the binding of vesticles to human erythrocytes and resulted in about 80 percent of the vesicle lipid and contents being associated with cells.

Citing Articles

Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies.

Naghib S, Mohammad-Jafari K Curr Top Med Chem. 2024; 24(14):1185-1211.

PMID: 38424436 DOI: 10.2174/0115680266286460240220073334.


Nanomedicine in cancer therapy.

Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T Signal Transduct Target Ther. 2023; 8(1):293.

PMID: 37544972 PMC: 10404590. DOI: 10.1038/s41392-023-01536-y.


Biomedicine Innovations and Its Nanohydrogel Classifications.

Makhathini S, Mdanda S, Kondiah P, Kharodia M, Rumbold K, Alagidede I Pharmaceutics. 2022; 14(12).

PMID: 36559335 PMC: 9787506. DOI: 10.3390/pharmaceutics14122839.


Surface Presentation of Hyaluronic Acid Modulates Nanoparticle-Cell Association.

Deiss-Yehiely E, Brucks S, Boehnke N, Pickering A, Kiessling L, Hammond P Bioconjug Chem. 2022; 33(11):2065-2075.

PMID: 36282941 PMC: 9942780. DOI: 10.1021/acs.bioconjchem.2c00412.


Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy.

Foglizzo V, Marchio S Cancers (Basel). 2022; 14(10).

PMID: 35626078 PMC: 9139219. DOI: 10.3390/cancers14102473.